According to Biolase 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0503467. At the end of 2023 the company had a P/S ratio of 0.0390.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.0390 | -59.26% |
2022 | 0.0958 | -93.72% |
2021 | 1.53 | -10.82% |
2020 | 1.71 | 272.09% |
2019 | 0.4597 | 1.71% |
2018 | 0.4520 | -51.4% |
2017 | 0.9299 | -49.07% |
2016 | 1.83 | 80.71% |
2015 | 1.01 | -68.5% |
2014 | 3.21 | 81.7% |
2013 | 1.77 | 78.41% |
2012 | 0.9894 | -38.56% |
2011 | 1.61 | -0.92% |
2010 | 1.63 | 51.33% |
2009 | 1.07 | 92.15% |
2008 | 0.5590 | -34% |
2007 | 0.8469 | -71.63% |
2006 | 2.98 | -0.58% |
2005 | 3.00 | -25.8% |
2004 | 4.05 | -45.11% |
2003 | 7.37 | 92.99% |
2002 | 3.82 | -39.16% |
2001 | 6.28 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Align Technology
ALGN | 4.30 | 8,443.10% | ๐บ๐ธ USA |
![]() Dentsply Sirona
XRAY | 1.71 | 3,294.42% | ๐บ๐ธ USA |